ArticleExperimental hematology & oncology2024

Novel CAR T-cell therapies for relapsed/refractory B-cell malignancies: latest updates from 2023 ASH annual meeting.

Wenjie Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.